USP Center in Ghana Receives International Lab Accreditation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

USP Center in Ghana Receives International Lab Accreditation


The US Pharmacopeial Convention (USP) has announced that its Center for Pharmaceutical Advancement and Training has received a top international laboratory accreditation. Launched in May 2013 to promote access to good quality medicines, the center is one of the only few laboratories in Sub-Saharan Africa to meet internationals standards in conducting quality control testing of medicines. The center serves all Sub-Saharan Africa—a region facing serious health issues and a proliferation of substandard and counterfeit medicines.

“We serve as a resource to countries throughout Sub-Saharan Africa by equipping regulatory authorities, manufacturers, quality control professionals, and others in the pharmaceutical industry with knowledge and skills to help ensure good quality medicines,” said Patrick Lukulay, PhD, vice-president for the USP department overseeing this effort, in a press release.

“Having an internationally accredited laboratory available as a training facility is a tremendous resource for the entire region,” said Lukulay. “The ISO 17025 accreditation, which came in record time, demonstrates the quality of our programs, the dedication of our staff in Ghana and USP’s commitment to global health.”

The center, located in Accra, Ghana, received the ISO 17025 accreditation from ACLASS, one of the three brands of the ANSI-ASQ National Accreditation Board, an internationally recognized body responsible for granting ISO/IEC accreditations to high quality testing and calibration laboratories. Preparations for obtaining the lab accreditation took place as staff was conducting training programs for regulators and manufacturers in quality control, GMPs, and dossier evaluation.

Source: USP.org

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here